ALX Oncology Holdings Inc. (ALXO) NASDAQ

1.29

-0.03(-2.27%)

Updated at February 04 04:00PM

Currency In USD

Valuation

Market Cap640.09M
Enterprise Value634.88M
P/E Ratio-0.45
PEG Ratio-0.02
Price/Sales Ratio27.43
Price/Book Ratio0.5
Enterprise/Revenue24.91
Enterprise/EBITDA-0.42

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-60.95
Operating Margin-64.47

Management Effectiveness

Return On Assets-0.81
Return On Equity-0.93

Income Statement

Revenue0
Revenue/Share0.05
Gross Profit-836,000
EBITDA-158.4M
Net Income-160.81M
Diluted EPS-3.74

Balance Sheet

Total Cash148.57M
Total Cash/Share2.82
Total Debt9.84M
Total Debt/Equity0.07
Current Ratio4.82
Book Value Per Share2.6

Price History

52-Week Change-91.76
52-Week High17.83
52-Week Low1.19
Moving Average 50 Days1.59
Moving Average 200 Days4.99

Statistics

Average Volume1.16M
Shares Outstanding52.74M
% Held by Institutions86.27

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A